ICON Public Limited Company

NASDAQ:ICLR

Medical - Diagnostics & Research

Healthcare
$195.16 -0.19%

-$0.27 today

Market cap
$14.62B
Beta
1.27
P/E (TTM)
23.0
EPS (TTM)
$6.23
52W Low $66.57High $211.00

Volume 0.55M

Average 1.15M

ICLR Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

ICON Public Limited CompanyNASDAQ: ICLR

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue growth accelerates

Q2 FY2026 cost of revenue of $1.67B rose 15.1% year over year, ahead of the +11.6% change in trailing-twelve-month cost of revenue. Sequentially, it rose 7.6% from the prior quarter. Over 3 fiscal years it compounded at +3.2% a year.

Context

  • Cost of revenue amounted to 73.6% of revenue in FY2025, up 3.1 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +15.1% holds above the trailing-twelve-month pace of +11.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.67B+7.6% QoQ
Last fiscal yearDec 2025
$6.08B+3.9% YoY
LTMJun 2026
$6.45B+11.6% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.1%——
1 year+3.9%——
3-year CAGR+3.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
6.08B USD
Year-over-year change
+3.9%
4-year CAGR
+11.2%

Cost of Revenue vs competitors

How ICLR compares with its peers on the latest reported figures

  • ICLR's LTM Jun 2026 cost of revenue of $6.45B is the 3rd highest of the 6 companies compared; the peer median is $2.71B.
  • Its year-over-year change of +11.6% is the 3rd highest of 6, against a peer median of +6.8%.
  • Cost of revenue amounts to 78.2% of revenue for ICLR, versus a peer median of 72.2%.
ICLR Competitors Peer median
Cost of Revenue for ICLR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$12.53B +21.4%+5.1%73.8%
LHLabcorp Holdings Inc.LTM Jun 2026$10.35B +6.8%+7.8%72.2%
ICLRICON Public Limited CompanyLTM Jun 2026$6.45B +11.6%+3.2%78.2%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$2.71B -0.4%+3.5%67.8%
FTREFortrea Holdings Inc.LTM Jun 2026$2.22B +0.2%+2.8%82.9%
MEDPMedpace Holdings, Inc.LTM Sep 2026$2.01B +23.8%+19.9%70.9%
Peer median (excluding ICLR) $2.71B+6.8%+5.1%72.2%

Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.48B7.74B8.12B8.28B8.25B
Cost of Revenue3.97B5.53B5.72B5.85B6.08B
Gross Profit1.51B2.21B2.4B2.44B2.18B
Gross Margin27.5%28.6%29.6%29.4%26.4%
Research & Development00000
Selling, General & Admin585.33M778.75M776.36M728.35M780.14M
Operating Expenses1.13B1.42B1.44B1.34B1.16B
Depreciation & Amortization314.99M569.51M585.95M488.5M383M
EBITDA694.09M1.37B1.52B1.56B823.57M
EBITDA Margin12.7%17.7%18.7%18.9%10.0%
Operating Income378.53M795.24M956.15M1.1B1.01B
Operating Margin6.9%10.3%11.8%13.3%12.3%
Interest Income574K2.35M5.01M8.61M7.11M
Interest Expense182.42M229.73M336.7M237.24M188.11M
Other Income / Expenses(184.01M)(230.52M)(331.69M)(228.63M)(759.99M)
Income Before Tax194.52M564.72M624.08M869.18M252.47M
Pre-Tax Margin3.5%7.3%7.7%10.5%3.1%
Income Tax Expense41.33M59.41M11.75M77.71M23.13M
Net Income153.19M505.3M612.34M791.47M229.34M
Net Margin2.8%6.5%7.5%9.6%2.8%
EPS (Basic)2.286.207.469.602.92
EPS (Diluted)2.256.137.409.532.90
Weighted Avg Shares67.11M81.53M82.1M82.48M78.42M
Weighted Avg Shares (Diluted)68.07M82.47M82.72M83.03M78.97M

ICON Public Limited Company

NASDAQ:ICLR

Intrinsic Alpha fair value

Locked

Current Price

$195.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.